CTRI/2018/02/012128尚未招募未知
Comparison of effectiveness and safety of immunotherapy of warts withintralesional versus subcutaneous MMR vaccine: an open-label, randomized, clinicaltrial. - SCVSILMMR
Indian association of Dermatologists Venereologists and leprologists West Bengal0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female patients between 18 and 65 years of age (both inclusive).
- •ii.Multiple viral warts >= 2 including genital warts
- •iii.Patients who give their informed consent.
- •iv.Patients not having received any anti-wart treatment in the past 4 weeks
- •iv. Lack of viral diseases such as herpes and/or bacterial infections such as impetigo
排除标准
- •Pregnant and lactating women.
- •ii.Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid or other non-steroidal immunosuppressive drug use etc.).
- •iii.Any other systemic disease (eg. liver or kidney disorder).
- •iv. Presence of ulcerated or inflamed wart(s).
- •vi.Patients who participated in a clinical trial in the last 3 months.
研究者
相似试验
已完成
不适用
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Pre-viously Untreated Extensive-Stage Small-Cell Lung Cancer: A Systematic Review and Network Me-ta-analysisExtensive stage small cell lung cancerJPRN-UMIN000041702Showa University3,879
已完成
2 期
A clinical trial to study the effect of two drugs- Mycobacterium w vaccine and imiquimod in patients with genital wartsCTRI/2009/091/000055Department of Biotechnology Govt of India110
尚未招募
不适用
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancerACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50
进行中（未招募）
1 期
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantatiotransplantationCTIS2023-506601-19-00Centre Hospitalier Universitaire De Limoges200
招募中
2 期
Stem cell therapy in ALSIRCT20160809029275N2Mashhad University of Medical Sciences15